Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDDNA X Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | $5.04 | $5.04 | $5.04 |
| Q2 2026 | 1 | $5.22 | $5.22 | $5.22 |
| Q3 2026 | 1 | $5.04 | $5.04 | $5.04 |
| Q4 2026 | 1 | $4.86 | $4.86 | $4.86 |
DNA X Inc. Earnings Date And Information
DNA X Inc. last posted its earnings results on Wednesday, August 19th, 2026. The company reported $-1.05 earnings per share for the quarter, missing analysts' consensus estimates of $5.22 by $6.27. The company had revenue of 0 for the quarter and had revenue of 0 for the year. DNA X Inc. has generated $-29 earnings per share over the last year ($-28.58 diluted earnings per share) and currently has a price-to-earnings ratio of -1.81. DNA X Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
DNA X Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/19/2026 | Q2 2026 | $5.22 | -$0.92 | -6.14 | $35.70 M | $0 |
| 05/20/2026 | Q1 2026 | $5.04 | $5.01 | -0.03 | $35.00 M | $0 |
| 04/14/2026 | Q4 2025 | N/A | -$3.91 | N/A | $34.34 M | $-44,125,000 |
| 10/31/2025 | Q3 2025 | $5.40 | -$1.45 | -6.85 | $29.17 M | $16.21 M |
| 08/08/2025 | Q2 2025 | $0.72 | -$14.15 | -14.87 | $25.41 M | $11.19 M |
| 05/12/2025 | Q1 2025 | -$2.34 | $1.41 | 3.75 | $19.56 M | $16.72 M |
| 03/31/2025 | Q4 2024 | -$0.00 | -$78.06 | -78.06 | $14.78 M | $14.98 M |
| 11/13/2024 | Q3 2024 | -$0.66 | -$9.32 | -8.66 | $10.91 M | $15.02 M |
| 08/09/2024 | Q2 2024 | N/A | -$25.42 | N/A | $18.00 M | $11.52 M |
| 05/14/2024 | Q1 2024 | N/A | -$12.11 | N/A | $27.57 M | $16.78 M |
| 03/27/2024 | Q4 2023 | $1.80 | -$5.65 | -7.45 | $27.57 M | $13.43 M |
| 11/14/2023 | Q3 2023 | $0.01 | $2.27 | 2.26 | $28.00 M | $27.57 M |
| 08/14/2023 | Q2 2023 | N/A | $2.23 | N/A | $25.50 M | $26.84 M |
| 05/08/2023 | Q1 2023 | -$54.00 | $1.00 | 55 | $23.00 M | $25.80 M |
| 03/20/2023 | Q4 2022 | -$1.00 | -$4.60 | -3.6 | $20.50 M | $24.12 M |
| 11/14/2022 | Q3 2022 | -$2.00 | -$8.02 | -6.02 | $18.25 M | $20.50 M |
| 08/12/2022 | Q2 2022 | -$3.00 | -$39.44 | -36.44 | $16.05 M | $11.96 M |
| 05/10/2022 | Q1 2022 | -$0.01 | -$67.93 | -67.93 | $14.07 M | $13.26 M |
| 03/21/2022 | Q4 2021 | -$0.72 | -$112.18 | -111.46 | $12.97 M | $15.93 M |
| 11/11/2021 | Q3 2021 | N/A | -$235.35 | N/A | $12.97 M | $14.45 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
DNA X Inc. Earnings: FAQ's
The conference call for DNA X Inc.'s latest earnings report can be listened to online.
The conference call transcript for DNA X Inc.'s latest earnings report can be read online.
DNA X Inc. (:SONM) has a recorded net income of $-20,657,000.DNA X Inc. has generated $-28.58 earnings per share over the last four quarters.
DNA X Inc. (:SONM) has a price-to-earnings ratio of -1.81 and price/earnings-to-growth ratio is -0.01.